Search

Your search keyword '"Links M."' showing total 139 results

Search Constraints

Start Over You searched for: Author "Links M." Remove constraint Author: "Links M."
139 results on '"Links M."'

Search Results

1. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

2. Prognostic gene expression signature for high-grade serous ovarian cancer

Catalog

Books, media, physical & digital resources

3. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

4. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

5. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.

7. Prognostic gene expression signature for high-grade serous ovarian cancer

10. Acknowledgement to reviewers of social sciences in 2019

12. BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition.

13. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.

14. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

16. Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target

18. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53mutation status in ovarian mucinous tumors: implications for outcome analyses

19. RAD51B in familial breast cancer.

20. Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.

21. Are transposable elements drivers of effector birth and diversification in Leptosphaeria species?

23. Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

24. Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer.

25. Early change in tumor size from waterfall plot analysis and RECIST response as predictor of overall survival (OS) in advanced, chemotherapy-refractory colorectal cancer (ACRC): NCIC CTG/AGITG CO.17 study.

26. Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1.

27. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

28. Early change in tumor size from waterfall plot analysis and RECIST response as predictor of overall survival (OS) in advanced, chemotherapy-refractory colorectal cancer (ACRC): NCIC CTG/AGITG CO.17 study.

30. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

32. Combined modality therapy for pancreatic carcinoma: An Australian Pancreatic Cancer Group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI 5FU) and 3D conformal radiotherapy (RT)—Final outcomes

39. INFLUENCE OF MASS BURIAL OF ANIMAL CARCASSES ON THE TYPES AND QUANTITIES OF MICROORGANISMS WITHIN A BURIAL SITE.

41. Big Data is changing the battle against infectious diseases.

42. Chemoprotectants: A Review of their Clinical Pharmacology and Therapeutic Efficacy.

43. Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines.

44. Breaking bad news: realistic versus unrealistic hopes.

46. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

47. Internal evaluation of medical programs is more than housework: A scoping review.

48. Learning to be well in the health workplace: an integrated model.

49. A compassionate pause.

50. An intensive multilocation temporal dataset of fungal and bacterial communities in the root and rhizosphere of Brassica napus .